Lisa Hicks


Associate Scientist, Li Ka Shing Knowledge Institute


Dr. Lisa Hicks is a malignant hematologist at St. Michael’s Hospital with an academic focus on quality improvement and innovation. She uses traditional clinical epidemiology methods combined with quality improvement techniques to develop interventions to improve the safety and efficiency of patient care. Thematically, her work focuses on understanding drivers of over-utilization in healthcare and on developing strategies to decrease this phenomenon. She also has an interest in understanding and preventing harm from cancer treatments. In particular, Dr. Hicks leads research that aims to understand the risk of Hepatitis B Virus (HBV) reactivation in cancer patients and to explore how this risk is understood, communicated and managed by clinicians. Dr. Hicks is also an active contributor to the development of clinical practice guidelines. She collaborates in this work with Cancer Care Ontario (CCO) and the American Society of Hematology (ASH). Finally, Dr. Hicks has a large clinical practice in Human Immunodeficiency Virus (HIV) associated lymphoma and has led clinical studies in this area.

Dr. Hicks is a member of the ASH Committee on Quality, and Chairs the Choosing Wisely Task Force for ASH. Within Canada, Dr. Hicks is a member of the National Clinical Leaders Group for the Choosing Wisely Canada Campaign. She is also the St. Michael’s Hospital Lead for a Hospital initiative addressing overutilization. Finally, she is an active member of the CCO Hematology Disease Site Group and has been an expert contributor to the pan Canadian Oncology Drug Review process.

Recent Publications

  1. Hicks, LK, O'Brien, P, Sholzberg, M, Veloce, N, Trafford, A, Sinclair, D et al.. Tackling overutilization of hospital tests and treatments: Lessons learned from a grassroots approach. Healthc Manage Forum. 2018;31 (5):186-190. doi: 10.1177/0840470418781172. PubMed PMID:30133329 .
  2. Sholzberg, M, Teitel, J, Hicks, LK. The authors respond to "Is referral necessary for abnormal bleeding?". CMAJ. 2017;189 (44):E1369. doi: 10.1503/cmaj.733365. PubMed PMID:29109213 PubMed Central PMC5675547.
  3. Sholzberg, M, Teitel, J, Hicks, LK. A 24-year-old woman with heavy menstrual bleeding. CMAJ. 2017;189 (22):E779-E780. doi: 10.1503/cmaj.161469. PubMed PMID:28584042 PubMed Central PMC5461127.
  4. Fralick, M, Hicks, LK, Chaudhry, H, Goldberg, N, Ackery, A, Nisenbaum, R et al.. REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED). BMJ Qual Improv Rep. 2017;6 (1):. doi: 10.1136/bmjquality.u221651.w8161. PubMed PMID:28469907 PubMed Central PMC5411723.
  5. Tseng, EK, Hicks, LK. Value Based Care and Patient-Centered Care: Divergent or Complementary?. Curr Hematol Malig Rep. 2016;11 (4):303-10. doi: 10.1007/s11899-016-0333-2. PubMed PMID:27262855 .
  6. Hicks, LK, Rajasekhar, A, Bering, H, Carson, KR, Kleinerman, J, Kukreti, V et al.. Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology. Am. J. Hematol. 2016;91 (8):787-92. doi: 10.1002/ajh.24412. PubMed PMID:27152483 .
  7. Acuna, SA, Fernandes, KA, Daly, C, Hicks, LK, Sutradhar, R, Kim, SJ et al.. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada. JAMA Oncol. 2016;2 (4):463-9. doi: 10.1001/jamaoncol.2015.5137. PubMed PMID:26746479 .
  8. Hicks, LK, Lien, K, Chan, KK. ASCO Provisional Clinical Opinion for Hepatitis B Virus Screening Before Cancer Therapy: Are These the Right Tests in the Right Patients?. J Oncol Pract. 2015;11 (4):e490-4. doi: 10.1200/JOP.2015.004945. PubMed PMID:26188049 .
  9. Wong, WW, Hicks, LK, Tu, HA, Pritchard, KI, Krahn, MD, Feld, JJ et al.. Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis. Breast Cancer Res. Treat. 2015;151 (3):639-52. doi: 10.1007/s10549-015-3382-7. PubMed PMID:25962692 .
  10. Visram, A, Chan, KK, McGee, P, Boro, J, Hicks, LK, Feld, JJ et al.. Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening. PLoS ONE. 2015;10 (4):e0120749. doi: 10.1371/journal.pone.0120749. PubMed PMID:25875198 PubMed Central PMC4398053.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Department of Medicine, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto